Featured Posters & Presentations
Zynteglo
Safety and efficacy of lentiGlobin gene therapy for transfusion-dependent β-thalassemia (TDT) in patients with non-β0/β0 genotypes: interim results from the HGB-204 (Northstar) and HGB-207 (Northstar-2) Trials.
Authors: Porter JB.
Zynteglo
Co-morbidities in transfusion dependent beta (β)-thalassaemia patients in England: A 10-year retrospective cohort analysis.
Authors: Jobanputra M.
Zynteglo
In-Hospital death in transfusion-dependent beta (β)-thalassaemia in England: A 10-year retrospective cohort analysis.
Authors: Jobanputra M.